Michael Cruse's most recent trade in Reneo Pharmaceuticals Inc was a trade of 125,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Dec. 9, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reneo Pharmaceuticals Inc | Michael Cruse | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 125,000 | 125,000 | - | - | Stock option (right to buy) | |
| Reneo Pharmaceuticals Inc | Michael Cruse | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 3.39 per share. | 01 Sep 2022 | 7,500 | 13,697 | - | 3.4 | 25,448 | Common Stock |
| Reneo Pharmaceuticals Inc | Michael Cruse | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 3.21 per share. | 29 Aug 2022 | 3,212 | 6,197 | - | 3.2 | 10,307 | Common Stock |
| Reneo Pharmaceuticals Inc | Michael Cruse | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 3.19 per share. | 29 Aug 2022 | 1,845 | 2,985 | - | 3.2 | 5,893 | Common Stock |
| Reneo Pharmaceuticals Inc | Michael Cruse | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 3.24 per share. | 29 Aug 2022 | 1,140 | 1,140 | - | 3.2 | 3,694 | Common Stock |
| Reneo Pharmaceuticals Inc | Michael Cruse | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 3.16 per share. | 29 Aug 2022 | 975 | 31,758 | - | 3.2 | 3,081 | Common Stock |
| Reneo Pharmaceuticals Inc | Michael Cruse | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 3.24 per share. | 29 Aug 2022 | 83 | 30,783 | - | 3.2 | 269 | Common Stock |
| Reneo Pharmaceuticals Inc | Michael Cruse | Senior VP-Corporate Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 75,000 | 75,000 | - | - | Stock option (right to buy) | |
| Reneo Pharmaceuticals Inc | Michael Cruse | Senior VP-Corporate Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 25,000 | 29,100 | - | 0 | Common Stock | |
| Reneo Pharmaceuticals Inc | Michael Cruse | Senior VP-Corporate Operations | Purchase of securities on an exchange or from another person at price $ 7.45 per share. | 25 Aug 2021 | 2,500 | 2,500 | - | 7.4 | 18,616 | Common Stock |